enGene Therapeutics Inc ENGN

US Healthcare Biological Products, (No Diagnostic Substances)
$1.78
+1.1%
52w: $1.44 – $12.17

Latest 13F among current holders filed 37 days ago (May 29, 2026)

Price — last 12 months

research preview data
1.446.8012.17
Jun 20, 2025 Jul 2, 2026
Institutional holders
70
+1 QoQ
13F value
$395.3M
-27.3% QoQ
Smart-money holders
23
signal tier ≥ 2
New smart buyers
2
Q1 2026
Options barometer
calls only
$175K calls / — puts

Institutional value by quarter

$564.7M
Q1 2024
$325.0M
Q2 2024
$236.9M
Q3 2024
$278.7M
Q4 2024
$186.3M
Q1 2025
$150.8M
Q2 2025
$282.4M
Q3 2025
$543.9M
Q4 2025
$395.3M
Q1 2026

Number of holders

43
Q1 2024
42
Q2 2024
41
Q3 2024
45
Q4 2024
41
Q1 2025
47
Q2 2025
49
Q3 2025
69
Q4 2025
70
Q1 2026

Who owns ENGN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
FCPM III SERVICES B.V. ★3Fundamental concentrated9.6M$65.6M9.1%Held
PERCEPTIVE ADVISORS LLC ★2Fundamental diversified5.8M$39.7M0.8%-0.7%
Siren, L.L.C. ★2Fundamental diversified5.3M$35.8M1.0%+57.5%
Venrock Adviser, LLC ★3Fundamental concentrated4.8M$32.5M1.2%Held
Blue Owl Capital Holdings LP ★2Fundamental diversified4.4M$30.1M8.1%+31.4%
Deep Track Capital, LP ★2Fundamental diversified4.4M$29.8M0.6%Held
BRAIDWELL LP ★2Fundamental diversified2.5M$16.7M0.6%-21.5%
Nextech Invest, Ltd. ★3Fundamental concentrated2.3M$15.8M1.1%+9.4%
Vestal Point Capital, LP ★2Fundamental diversified2.2M$14.7M0.4%+105.2%
MPM BIOIMPACT LLC ★2Fundamental concentrated1.8M$12.6M1.0%+0.2%
Kynam Capital Management, LP ★3Fundamental concentrated1.4M$9.2M0.6%-9.1%
FRANKLIN RESOURCES INC Long only active1.3M$9.0M0.0%-5.3%
Polar Capital Holdings Plc Other1.2M$8.3M0.0%+7.1%
Balyasny Asset Management L.P. Multistrat pod1.1M$7.8M0.0%New
FCPM III SERVICES B.V. ★3Fundamental concentrated2.9M$7.3M1.0%Held
MILLENNIUM MANAGEMENT LLC Multistrat pod959.7K$6.5M0.0%-36.0%
Omega Fund Management, LLC ★3Fundamental concentrated876.4K$6.0M3.7%Held
SR One Capital Management, LP ★3Fundamental concentrated747.8K$5.1M0.6%Held
Affinity Asset Advisors, LLC ★2Fundamental diversified610.4K$4.2M0.2%-5.1%
Eversept Partners, LP ★2Fundamental diversified510.5K$3.5M0.2%+12.0%
KENNEDY CAPITAL MANAGEMENT LLC Other425.8K$2.9M0.1%+454.7%
BVF INC/IL ★3Fundamental concentrated945.4K$2.5M0.1%Held
Privium Fund Management B.V. ★2Fundamental diversified352.1K$2.4M0.5%Held
MARSHALL WACE, LLP Quant stat arb343.9K$2.3M0.0%New
Monashee Investment Management LLC ★2Fundamental diversified320.0K$2.2M1.2%+8.5%
Birchview Capital, LP ★2Fundamental diversified250.0K$1.7M1.0%New
Woodline Partners LP Other250.0K$1.7M0.0%Held
FMR LLC Long only active232.2K$1.6M0.0%New
Elmind Capital, LP ★3Fundamental concentrated210.0K$1.4M0.4%Held
Blue Owl Capital Holdings LP ★2Fundamental diversified511.2K$1.3M0.3%+1316.0%
DAFNA Capital Management LLC ★2Fundamental diversified187.4K$1.3M0.3%+14.5%
Point72 Asset Management, L.P. Multistrat pod173.4K$1.2M0.0%-69.1%
TWO SIGMA INVESTMENTS, LP Quant stat arb159.1K$1.1M0.0%-1.5%
RENAISSANCE TECHNOLOGIES LLC Quant stat arb156.1K$1.1M0.0%+651.1%
JANE STREET GROUP, LLC Market maker156.0K$1.1M0.0%+176.3%
CITADEL ADVISORS LLC Multistrat pod153.9K$1.0M0.0%+506.5%
ADAR1 Capital Management, LLC Other133.7K$910K0.1%-56.0%
LMR Partners LLP Quant stat arb320.7K$811K0.0%+303.2%
Trexquant Investment LP Diversified mechanical104.7K$713K0.0%New
XTX Topco Ltd Market maker93.5K$637K0.0%+290.8%
MORGAN STANLEY Bank broker86.6K$590K0.0%-87.9%
ARISTEIA CAPITAL, L.L.C. Quant stat arb164.5K$445K0.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker65.3K$445K0.0%+82.0%
SEI INVESTMENTS CO Diversified mechanical60.0K$409K0.0%New
Squarepoint Ops LLC Quant stat arb48.9K$333K0.0%New
D. E. Shaw & Co., Inc. Quant stat arb104.6K$275K0.0%Held
GEODE CAPITAL MANAGEMENT, LLC Index provider38.8K$264K0.0%+33.7%
DIMENSIONAL FUND ADVISORS LP Quant stat arb36.9K$251K0.0%New
Quadrature Capital Ltd Diversified mechanical33.8K$230K0.0%-30.4%
AMERICAN CENTURY COMPANIES INC Diversified mechanical32.9K$224K0.0%+37.0%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.